SB 526 – Maryland

Status: In Process
Year Introduced: 2024

Prohibiting certain pharmacy benefits managers from requiring a beneficiary to use a specific pharmacy or entity for a specialty drug if the drug is dispensed by a physician, used in the treatment of a certain condition, and meets other requirements; and altering the application to specialty drugs of the prohibition on certain pharmacy benefits managers reimbursing a pharmacy or pharmacist in an amount less than the amount the pharmacy benefits manager reimburses itself or an affiliate for providing the same product or service.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found